Global Positron Emission Tomography Market

Positron Emission Tomography Market Size, Share, Growth Analysis, By Product (Standalone PET Systems, PET/CT Systems), By Application (Oncology Applications, Neurological Applications), By End User (Hospitals & Surgical Centers, Diagnostic & Imaging Clinics), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2276 | Region: Global | Published Date: November, 2024
Pages: 204 |Tables: 89 |Figures: 71

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Positron Emission Tomography Market size was valued at USD 2.69 Billion in 2024 and is poised to grow from USD 2.86 Billion in 2025 to USD 4.78 Billion by 2033, growing at a CAGR of 6.61% during the forecast period (2026–2033).

    Global Positron Emission Tomography market is fiercely competitive, with major players such as Siemens Healthineers, GE Healthcare, and Philips Healthcare, which forge ahead through technical innovation and extensive product portfolios. These companies are competing to develop enhanced PET technologies while integrating AI for precision in diagnosis. Small-scale companies and recent entrants join in by offering specialized solutions and lower prices. The market players are working towards continuous innovations and strategic alliances to achieve more capability and better market access. 'General Electric ', 'Koninklijke Philips N.V. ', 'Siemens Healthineers ', 'Shanghai United Imaging Healthcare Co., Ltd ', 'Canon Inc. ', 'Shimadzu Corporation ', 'Mediso Ltd. ', 'MinFound Medical Systems Co., Ltd ', 'Neusoft Corporation ', 'Bruker ', 'CMR Naviscan ', 'Kindsway Biotech ', 'Hermes Medical Solutions ', 'Sofie Biosciences ', 'Prescient Medical Imaging ', 'Reflexion ', 'Cubresa Inc. ', 'Synchropet, Inc. ', 'Novartis ', 'Revvity Inc.'

    The increasing prevalence of chronic diseases, such as cancer, Alzheimer's disease, and cardiovascular disorders, is one of the major driving forces behind the market growth. Most of the disorders require advanced imaging for diagnosis and monitoring. In this sense, PET scans are indispensable, as they offer detailed information about metabolic and physiological processes, very much essential for successful treatment planning and management of the disease. The rise in patients with chronic diseases globally creates demand for PET scans, hence driving the growth of the market. This trend shows how advanced diagnostic tools cope with the complexity associated with managing chronic medical conditions.

    Machine Learning combined with Artificial Intelligence: The integration of AI and machine learning into the scanning equipment is basically the trend that forces a leading pace in the industry. AI algorithms improve picture capture, reconstruction, and analysis for better diagnostic accuracy and speed. These advantages involve improved identification of minor anomalies, more exact tumor characterization, and faster times of scans. Machine learning algorithms might be used to predict patient outcomes and personalize treatment strategies with the help of imaging data. With the continuous improvement and development in AI and machine learning, their involvement is expected to bring great changes to the capability of PET scan capability, therefore making it more useful and available to both clinical and research settings.

    By revenue share, North America accounted for about 34.11% of the market in 2023. The solid demand for precision diagnosis, coupled with technological advances in PET imaging for cancer and advanced diagnostic applications, provides a considerable impetus to market growth. This trend is additionally driven by the growing incidence of cancer, especially prostate and breast cancers. According to an update from the American Cancer Society in 2022, it is projected that there will be an estimated 1,918,030 new cancer cases diagnosed in the US in 2022, which includes an estimated 290,560 new cases of invasive breast cancer, 268,490 new cases of invasive prostate cancer, and 151,030 new cases of invasive colorectal cancer. These figures illustrate precisely how immense a need there is for better cancer imaging tools.

    Related Reports

    Optical Emission Spectroscopy Market
    Buy Now GET FREE SAMPLE
    Emission Monitoring Systems Market
    Buy Now GET FREE SAMPLE
    Spectral Computed Tomography Market
    Buy Now GET FREE SAMPLE
    Optical Coherence Tomography Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Positron Emission Tomography Market

    Report ID: SQMIG35D2276

    $5,300
    BUY NOW